Albumin Replacement Therapy: an Effective Way to Remove Blood Bilirubin
GONG Dehua,JI Daxi,REN Bing,TAO Jing,XU Bing,LI Leishi
DOI: https://doi.org/10.3969/j.issn.1006-298x.2007.03.008
2007-01-01
Abstract:Objective:To treat patients with hyperbilirubinemia by albumin replacement therapy (ART) using secondary plasma separator, and investigate the effect of ART on blood bilirubin and other substances removal. Methodology:Seven patients with hyperbilirubinemia received total 12 sessions ART. ART was performed with 10-hour duration, in a way similar with post-dilution continuous veno-venous hemofiltration (CVVH). A secondary plasma separator EC20W or EC30W was used as hemofilter, and albumin was added into substitution fluid. The flow rate of blood and substitution fluid was set at 250 ml/min, 33.3 ml/min, respectively. The removal of blood bilirubin, protein and effect on hemostasis parameters were evaluated during ART treatment. Results:In 5 sessions of ART using EC20W, the reduction ratio (RR) of blood total bilirubin (TB), direct bilirubin (DB), indirect bilirubin (IDB) after a single treatment was (29.1±3.0)%,(31.3±4.5)%,(18.7±10.2)%,respectively. In 7 sessions of ART using EC30W, the RR of TB, DB, IDB was (52.4±7.5)%,(54.9±9.4)%,(45.7±10.9)%, respectively. The clearance of TB at initiation of ART was (11.1±1.3) ml/min (using EC20W), and (14.5±1.6) ml/min (using EC30W, P0.01), which progressively decreased to (4.4±0.5) ml/min (using EC20W),(8.6±1.2) ml/min (using EC30W, P0.01) at the end of treatment. After treatment using EC20W, the levels of blood total protein, albumin, IgA, IgM had little changes, and the levels of blood globulin and IgG decreased slightly. After treatment using EC30W, the levels of blood total protein, albumin, globulin, IgG, IgA decreased significantly, but blood IgM level increased obviously. The total removal amount of albumin and globulin per treatment using EC20W was (95.0±27.2) g, and (22.4±9.3) g, while they were (164.6±18.3) g, (29.5±8.3) g when EC30W was used. ART had no effect on blood fibrogen levels using EC20W or EC30W, but could correct prolonged prothrombin time using EC20W. Conclusion:Albumin replacement therapy using EC20W can separate blood albumin and its binding bilirubin with high selectivity, and has little effect on immune globulin with molecular weight larger than albumin, and correct hemostasis abnormalities.